120 related articles for article (PubMed ID: 19774948)
1. Clinical significance of p53 and bcl-2 protein coexpression phenotypes in molecular breast cancer subtypes of pre-menopausal and post-menopausal African-American women.
Ihemelandu CU; Dewitty RL; Leffall LD; Suryanarayana SM; Frederick WA
Am Surg; 2009 Sep; 75(9):776-84; discussion 784. PubMed ID: 19774948
[TBL] [Abstract][Full Text] [Related]
2. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
[TBL] [Abstract][Full Text] [Related]
3. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
Ann Surg Oncol; 2007 Oct; 14(10):2994-3003. PubMed ID: 17647064
[TBL] [Abstract][Full Text] [Related]
4. Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer.
Al-Moundhri M; Nirmala V; Al-Mawaly K; Ganguly S; Burney I; Rizvi A; Grant C
Pathol Oncol Res; 2003; 9(4):226-31. PubMed ID: 14688828
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
[TBL] [Abstract][Full Text] [Related]
6. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
[TBL] [Abstract][Full Text] [Related]
7. Correlation between ER, PR, HER-2, Bcl-2, p53, proliferative and apoptotic indexes with HER-2 gene amplification and TOP2A gene amplification and deletion in four molecular subtypes of breast cancer.
Mitrović O; Čokić V; Đikić D; Budeč M; Vignjević S; Subotički T; Gulan M; Radović S; Furtula S
Target Oncol; 2014 Dec; 9(4):367-79. PubMed ID: 24272208
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
Nakopoulou L; Michalopoulou A; Giannopoulou I; Tzonou A; Keramopoulos A; Lazaris AC; Davaris PS
Histopathology; 1999 Apr; 34(4):310-9. PubMed ID: 10231398
[TBL] [Abstract][Full Text] [Related]
9. Analysis of bcl-2 in sporadic breast carcinoma.
Dueñas-González A; Abad-Hernández MM; Cruz-Hernández JJ; González-Sarmiento R
Cancer; 1997 Dec; 80(11):2100-8. PubMed ID: 9392332
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.
Huo D; Hu H; Rhie SK; Gamazon ER; Cherniack AD; Liu J; Yoshimatsu TF; Pitt JJ; Hoadley KA; Troester M; Ru Y; Lichtenberg T; Sturtz LA; Shelley CS; Benz CC; Mills GB; Laird PW; Shriver CD; Perou CM; Olopade OI
JAMA Oncol; 2017 Dec; 3(12):1654-1662. PubMed ID: 28472234
[TBL] [Abstract][Full Text] [Related]
13. [The expression of bcl-2, P53 and c-erbB-2 onco-proteins in breast cancer and their clinicopathological significance].
Gao L; Ding H; Deng Y
Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):165-8. PubMed ID: 9275673
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.
Kim K; Chie EK; Han W; Noh DY; Park IA; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
J Korean Med Sci; 2010 Feb; 25(2):235-9. PubMed ID: 20119576
[TBL] [Abstract][Full Text] [Related]
15. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
16. [Different phenotypes generated by changes in bcl-2 and p53 expression in breast cancer].
Cianga C; Cianga P; Cozma L; Chifu C; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):831-5. PubMed ID: 16610184
[TBL] [Abstract][Full Text] [Related]
17. MMP-1 expression has an independent prognostic value in breast cancer.
Boström P; Söderström M; Vahlberg T; Söderström KO; Roberts PJ; Carpén O; Hirsimäki P
BMC Cancer; 2011 Aug; 11():348. PubMed ID: 21835023
[TBL] [Abstract][Full Text] [Related]
18. Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women.
Ihemelandu CU; Naab TJ; Mezghebe HM; Makambi KH; Siram SM; Leffall LD; Dewitty RL; Frederick WA
Am J Surg; 2008 Feb; 195(2):153-8. PubMed ID: 18083134
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
